Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Continuous
Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
N Engl J Med 2012; 366:1759-1769May 10, 2012, DOI: 10.1056/NEJMoa1112704

Antonio Palumbo, M.D., Roman Hajek, M.D., Ph.D., Michel Delforge, M.D., Ph.D.,

Martin Kropff, M.D., Maria Teresa Petrucci, M.D., John Catalano, M.B., B.S.,
Heinz Gisslinger, M.D., Wies?aw Wiktor-Je;drzejczak, M.D., Ph.D.,
Mamia Zodelava, M.D., Ph.D., Katja Weisel, M.D., Nicola Cascavilla,
M.D., Genadi Iosava, M.D., Michele Cavo, M.D., Janusz Kloczko, M.D., Ph.D.,
Joan Bladé, M.D., Meral Beksac, M.D., Ivan Spicka, M.D., Ph.D., Torben Plesner, M.D.,
Joergen Radke, M.D., Christian Langer, M.D., Dina Ben Yehuda, M.D., Alessandro Corso, M.D.,
Lindsay Herbein, B.S., Zhinuan Yu, Ph.D., Jay Mei, M.D., Ph.D., Christian Jacques, M.D., and
Meletios A. Dimopoulos, M.D. for the MM-015 Investigators